✦ LIBER ✦

864 Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy

✍ Scribed by M. Ikeda; K. Matsumoto; K. Tabata; S. Minamida; T. Fujita; T. Satoh; M. Iwamura; S. Baba

Book ID: 119624795
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 16 KB
Volume: 11
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(12)60861-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine plus carboplatin; and gemcit

Gemcitabine plus carboplatin; and gemcitabine, docetaxel, and carboplatin combined chemotherapy regimens in patients with metastatic urothelial carcinoma previously treated with a platinum-based regimen: preliminary report

✍ Senji Hoshi; Chikara Ohyama; Kunio Ono; Atsushi Takeda; Shinichi Yamashita; Taka 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 189 KB

Methotrexate, vinblastine, doxorubicin a

Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy

✍ Han, K S; Joung, J Y; Kim, T S; Jeong, I G; Seo, H K; Chung, J; Lee, K H 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Platinum-free combination chemotherapy i

Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma : A Phase I/II trial of gemcitabine, paclitaxel, and methotrexate

✍ Primo N. Lara Jr; Frederick J. Meyers; Lisa Y. Law; Nancy A. Dawson; Joan Housto 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## BACKGROUND Platinum‐based regimens have improved response rates and survival in patients with advanced transitional cell carcinoma (TCC) of the urothelial tract. However, the toxicities of platinum‐based chemotherapy are considerable. Regimens with reduced toxicity that are applicab

A phase II study of irinotecan and docet

A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer

✍ Sun Jin Sym; Heung Moon Chang; Hye Jin Kang; Sung Sook Lee; Min-Hee Ryu; Jae-Lyu 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 336 KB

A phase II study of irinotecan plus cisp

A phase II study of irinotecan plus cisplatin for patients with advanced stage IIIB or IV NSCLC previously treated with nonplatinum-based chemotherapy

✍ Heung T. Kim; Ji-Youn Han; Dae H. Lee; Jong H. Chun; Hong G. Lee; Jae J. Lee; Hy 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Combination of gemcitabine and carboplat

Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract

✍ Joo Hee Park, Soon Wook Lee, Hye Sook Kim… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 239 KB